Transgenomic's Q1 Revenues Increase 2 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Wednesday that its first-quarter revenues inched up 2 percent as an increase in sales from its laboratory services unit were offset by lower instrument sales.

The Omaha, Neb.-based molecular diagnostics firm reported total revenues of $7.4 million for the three months ended March 31, compared to $7.2 million for the first quarter of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.